Skip to main content

Table 1 Baseline characteristics of the study cohort (n = 543).

From: Plasma suPAR levels are associated with mortality, admission time, and Charlson Comorbidity Index in the acutely admitted medical patient: a prospective observational study

Variable (unit)

N

Median or percent

2.5th Percentile

97.5th Percentile

Age (years)

543

68.8

24.2

92.7

Sex

    

   Male

252

46.4 %

-

-

   Female

291

53.6 %

-

-

Baseline diagnosis

    

   Symptoms, signs or for observationa

126

23.2 %

-

-

   Respiratory disease

112

20.6 %

-

-

   Cardiovascular disease

88

16.2 %

-

-

   Endocrine disease

43

7.9 %

-

-

   Infectious diseaseb

36

6.6 %

-

-

   Hematological disease

26

4.8 %

-

-

   Other

112

20.6 %

-

-

Charlson Score

    

0

342

63.0 %

-

-

1

152

28.0 %

-

-

2

35

6.45 %

-

-

3

9

1.66 %

-

-

4+

5

0.92 %

-

-

SuPAR (ng/ml)

543

4.28

1.81

13.6

Creatinine (μmol/l)

541

76.0

42.0

215

CRP (mg/l)

540

8.00

1.00

286

Leukocytes (109/l)

539

8.30

3.60

22.9

ALAT (U/l)

541

22.0

8.00

120

Albumin (g/l)

538

35.0

22.0

43.0

Hemoglobin (mmol/l)

541

7.90

5.00

9.90

  1. aICD-10 Chapter XVIII diagnoses (R00-R99) and Chapter XXI diagnoses (Z00-Z99) collapsed; bICD-10 Chapter I diagnoses (A00-B99). Some values were missing for biomarkers other than suPAR (samples failed because of hemolysis or because they were lost).